MedTrace Logo

Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer

NCT01759836 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 364

Last updated 2022-01-25

No results posted yet for this study

Summary

Biochemical recurrence develops in approximately 30-40% of men with locally advanced prostate cancer who undergo radical prostatectomy. To date, the effect of statins on prostate cancer recurrence has been investigated in several retrospective studies with inconsistent results. The purpose of this study is to determine the impact of statin on biochemical recurrence after radical prostatectomy for locally advanced prostate cancer.

Conditions

  • Prostatic Neoplasms

Interventions

DRUG

Atorvastatin 20mg

Atorvastatin 20mg daily for 1 year

Sponsors & Collaborators

  • Dong-A Pharmaceutical

    collaborator INDUSTRY

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Choung-Soo Kim, MD · Department of Urology,Asan Medical Center, Seoul

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01759836 on ClinicalTrials.gov